Entity Details

Primary name NRX1A_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9ULB1
EntryNameNRX1A_HUMAN
FullNameNeurexin-1
TaxID9606
Evidenceevidence at protein level
Length1477
SequenceStatuscomplete
DateCreated2001-11-16
DateModified2021-06-02

Ontological Relatives

GenesNRXN1

GO terms

Show/Hide Table
GOName
GO:0005246 calcium channel regulator activity
GO:0005509 calcium ion binding
GO:0005730 nucleolus
GO:0005783 endoplasmic reticulum
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0007158 neuron cell-cell adhesion
GO:0007268 chemical synaptic transmission
GO:0007269 neurotransmitter secretion
GO:0007411 axon guidance
GO:0007416 synapse assembly
GO:0007612 learning
GO:0009986 cell surface
GO:0030534 adult behavior
GO:0031965 nuclear membrane
GO:0031982 vesicle
GO:0033130 acetylcholine receptor binding
GO:0035176 social behavior
GO:0038023 signaling receptor activity
GO:0042297 vocal learning
GO:0042734 presynaptic membrane
GO:0042995 cell projection
GO:0043025 neuronal cell body
GO:0050839 cell adhesion molecule binding
GO:0050885 neuromuscular process controlling balance
GO:0051965 positive regulation of synapse assembly
GO:0051968 positive regulation of synaptic transmission, glutamatergic
GO:0071625 vocalization behavior
GO:0090129 positive regulation of synapse maturation
GO:0097104 postsynaptic membrane assembly
GO:0097109 neuroligin family protein binding
GO:0097116 gephyrin clustering involved in postsynaptic density assembly
GO:0097118 neuroligin clustering involved in postsynaptic membrane assembly
GO:0097119 postsynaptic density protein 95 clustering
GO:2000463 positive regulation of excitatory postsynaptic potential

Subcellular Location

Show/Hide Table
Subcellular Location
Cell junction

Domains

Show/Hide Table
DomainNameCategoryType
IPR000152 EGF-type aspartate/asparagine hydroxylation sitePTMPTM
IPR000742 EGF-like domainDomainDomain
IPR001791 Laminin G domainDomainDomain
IPR003585 Neurexin/syndecan/glycophorin CDomainDomain
IPR013320 Concanavalin A-like lectin/glucanase domain superfamilyFamilyHomologous superfamily
IPR027789 Syndecan/Neurexin domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
614325 OMIMPitt-Hopkins-like syndrome 2 (PTHSL2)A syndrome characterized by severe mental retardation and variable additional symptoms, such as impaired speech development, autistic behavior, breathing anomalies and a broad mouth, resembling Pitt-Hopkins syndrome. Other features include decreased reflexes in the upper extremities, constipation, strabismus, and protruding tongue with drooling. In contrast to patients with Pitt-Hopkins syndrome, PTHSL2 patients present with normal or only mildly to moderately delayed motor milestones. The disease is caused by variants affecting the gene represented in this entry.
614332 OMIMSchizophrenia 17 (SCZD17)A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder. Disease susceptibility may be associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB11093 Calcium citrateDrugbanksmall molecule
DB11348 Calcium PhosphateDrugbanksmall molecule
DB14481 Calcium phosphate dihydrateDrugbanksmall molecule

Interactions

31 interactions

InteractorPartnerSourcesPublicationsLink
NRX1A_HUMANSI1L1_HUMANBioGRID, HPRD, IntAct12421765 details
NRX1A_HUMANMYO16_HUMANBioGRID, HPRD, IntAct12421765 details
NRX1A_HUMANPDZD2_HUMANBioGRID, HPRD, IntAct12421765 details
NRX1A_HUMANMACF1_HUMANBioGRID, IntAct12421765 details
NRX1A_HUMANNLGN1_HUMANBioGRID, HPRD12796785 14522992 8576240 details
NRX1A_HUMANSYT13_HUMANBioGRID, HPRD11171101 details
NRX1A_HUMANNLGN2_HUMANBioGRID, HPRD8576240 details
NRX1A_HUMANNLGN3_HUMANBioGRID, HPRD8576240 9325340 details
NRX1A_HUMANAFAD_HUMANBioGRID9707552 details
NRX1A_HUMANAT132_HUMANBioGRID22645275 details
NRX1A_HUMANCSKP_HUMANHPRD11036064 8786425 details
NRX1A_HUMANSDCB2_HUMANHPRD11152476 details
NRX1A_HUMANTULP1_HUMANBioGRID, IntAct27173435 unassigned1312 details
NRX1A_HUMANRHG10_HUMANBioGRID, IntAct27173435 unassigned1312 details
NRX1A_HUMANELOA1_HUMANBioGRID, IntAct27173435 unassigned1312 details
NRX1A_HUMANRHG26_HUMANBioGRID, IntAct27173435 unassigned1312 details
NRX1A_HUMANSYT1_HUMANHPRD11243866 8901523 details
NRX1A_HUMANSYT4_HUMANHPRD8901523 details
NRX1A_HUMANSYT2_HUMANHPRD8901523 details
NRX1A_HUMANSYT5_HUMANHPRD8901523 details
NRX1A_HUMANAPBA1_HUMANHPRD11036064 details
NRX1A_HUMANAPBA2_HUMANHPRD11036064 details
NRX1A_HUMANNXPH3_HUMANHPRD9856994 details
NRX1A_HUMANNXPH1_HUMANHPRD8699246 9856994 details
NRX1A_HUMANSYT6_HUMANHPRD8901523 details
NRX1A_HUMANSYT9_HUMANHPRD8901523 details
NRX1A_HUMANSYT7_HUMANHPRD8901523 details
NRX1A_HUMANNXPH2_HUMANHPRD8699246 details
NRX1A_HUMANSYTL1_HUMANHPRD11243866 details
NRX1A_HUMANRP3A_HUMANHPRD8901523 details
NRX1A_HUMANSYTL3_HUMANHPRD11243866 details